Alaunos Therapeutics Inc (TCRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 140,717 | 163,843 | 118,550 | 129,684 | 42,803 |
| Receivables | 446 | 369 | 89 | 62 | 145 |
| TOTAL | $152,521 | $172,480 | $123,080 | $130,603 | $44,087 |
| Non-Current Assets | |||||
| PPE Net | 581 | 262 | 321 | 426 | 531 |
| Other Non-Current Assets | 622 | 619 | 637 | 619 | 619 |
| TOTAL | $1,203 | $881 | $958 | $1,045 | $1,150 |
| Total Assets | $153,724 | $173,361 | $124,038 | $131,648 | $45,237 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,008 | 4,154 | 3,143 | 779 | 2,004 |
| Accrued Expenses | 8,906 | 18,138 | 8,752 | 8,220 | 7,182 |
| TOTAL | $18,123 | $29,627 | $13,110 | $10,492 | $10,826 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 7,209 | 7,335 | 1,215 | 1,493 | 1,640 |
| Other Non-Current Liabilities | 0 | 0 | 17 | 0 | 0 |
| TOTAL | $48,230 | $49,893 | $487 | $553 | $570 |
| Total Liabilities | $66,353 | $79,520 | $13,597 | $11,045 | $11,396 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 879 | 873 | 873 | 855 | 765 |
| Common Shares | 132 | 131 | 131 | 128 | 104 |
| Retained earnings | -492,700 | -483,224 | -465,054 | -450,843 | -372,612 |
| TOTAL | $87,371 | $93,841 | $110,441 | $120,603 | $33,841 |
| Total Liabilities And Equity | $153,724 | $173,361 | $124,038 | $131,648 | $45,237 |